Hollencrest Capital Management’s InspireMD NSPR Stock Holding History

Hollencrest Capital Management’s Portfolio NSPR Stock Details NSPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-20,000	Closed	-$48.2K	–	1229
2025 Q3	$48.2K	Hold	20,000	–	–	﹤0.01%	564
2025 Q2	$45.4K	Hold	20,000	–	–	﹤0.01%	535
2025 Q1	$53.8K	Hold	20,000	–	–	﹤0.01%	505
2024 Q4	$52.6K	Hold	20,000	–	–	﹤0.01%	524
2024 Q3	$53.6K	Hold	20,000	–	–	﹤0.01%	505
2024 Q2	$49.9K	Hold	20,000	–	–	﹤0.01%	514
2024 Q1	$47.4K	Hold	20,000	–	–	﹤0.01%	498
2023 Q4	$56.2K	Hold	20,000	–	–	0.01%	469
2023 Q3	$65.4K	Hold	20,000	–	–	0.01%	427
2023 Q2	$50.2K	Hold	20,000	–	–	0.01%	495
2023 Q1	$22.6K	Hold	20,000	–	–	﹤0.01%	618
2022 Q4	$17.2K	Hold	20,000	–	–	﹤0.01%	637
2022 Q3	$30K	Hold	20,000	–	–	﹤0.01%	299
2022 Q2	$40K	Hold	20,000	–	–	﹤0.01%	323
2022 Q1	$64K	Hold	20,000	–	–	0.01%	355
2021 Q4	$60K	Hold	20,000	–	–	﹤0.01%	366
2021 Q3	$82K	Hold	20,000	–	–	0.01%	366
2021 Q2	$101K	Buy	+20,000	New	+$121K	0.01%	366

Other funds holding NSPR

Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return

VCIM

Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

PVI

Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return

ISL

Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return

Hollencrest Capital Management's NSPR Position: Q4 2025 in Review

Hollencrest Capital Management sold out of InspireMD (NSPR) in Q4 2025, closing a stake of 20,000 shares — an estimated $48.2K sold.

Hollencrest Capital Management first reported a position in NSPR in Q2 2021 and held it in 18 quarters. The position peaked at $101K in Q2 2021. 45 funds tracked by Wall St. Rank hold NSPR as of Q4 2025.

Hollencrest Capital Management reported no remaining InspireMD position as of Q4 2025 after selling out during the quarter.
Hollencrest Capital Management sold 20,000 InspireMD shares in Q4 2025, an estimated $48.2K.
Hollencrest Capital Management first reported a position in InspireMD in Q2 2021 and held it in 18 quarters.
Hollencrest Capital Management's InspireMD position peaked at $101K in Q2 2021.
45 funds tracked by Wall St. Rank held InspireMD as of Q4 2025.

Based on Hollencrest Capital Management's 13F filing for Q4 2025, filed 12 Feb 2026.